Literature DB >> 30177435

The comings and goings of PARP-1 in response to DNA damage.

John M Pascal1.   

Abstract

Poly(ADP-ribose) polymerase (PARP) enzymes are broadly involved in the cellular response to DNA damage. PARP-1 is the chief human PARP enzyme involved in the DNA damage response, acting as a first responder that detects DNA strand breaks, and contributes to repair pathway choice and the efficiency of repair through modulation of chromatin structure and through interaction with and modification of a multitude of DNA repair factors. This perspective summarizes our knowledge of PARP-1 involvement in DNA repair pathways, and highlights recent structural and functional data regarding the activation of PARP-1 upon detecting DNA damage, and the release and trapping of PARP-1 at sites of DNA damage.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage response; PARP; Poly(ADP-ribose)

Mesh:

Substances:

Year:  2018        PMID: 30177435      PMCID: PMC6637744          DOI: 10.1016/j.dnarep.2018.08.022

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  73 in total

1.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

2.  PolyADP-Ribosylation of NFATc3 and NF-κB Transcription Factors Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury.

Authors:  Yunjuan Nie; Teja Srinivas Nirujogi; Ravi Ranjan; Brenda F Reader; Sangwoon Chung; Megan N Ballinger; Joshua A Englert; John W Christman; Manjula Karpurapu
Journal:  J Innate Immun       Date:  2020-10-12       Impact factor: 7.349

3.  Parp1 promotes sleep, which enhances DNA repair in neurons.

Authors:  David Zada; Yaniv Sela; Noa Matosevich; Adir Monsonego; Tali Lerer-Goldshtein; Yuval Nir; Lior Appelbaum
Journal:  Mol Cell       Date:  2021-11-18       Impact factor: 17.970

Review 4.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

5.  Treatment of human cells with 5-aza-dC induces formation of PARP1-DNA covalent adducts at genomic regions targeted by DNMT1.

Authors:  Kostantin Kiianitsa; Yinbo Zhang; Nancy Maizels
Journal:  DNA Repair (Amst)       Date:  2020-10-02

Review 6.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

Review 7.  Communication between chromatin and homologous recombination.

Authors:  Priyanka Verma; Roger A Greenberg
Journal:  Curr Opin Genet Dev       Date:  2021-06-05       Impact factor: 5.578

8.  VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases.

Authors:  Arun Kanakkanthara; Larry M Karnitz; Thomas L Ekstrom; Nicholas M Pathoulas; Amelia M Huehls
Journal:  Mol Cancer Ther       Date:  2021-06-17       Impact factor: 6.261

Review 9.  PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.

Authors:  Lotte van Beek; Éilís McClay; Saleha Patel; Marianne Schimpl; Laura Spagnolo; Taiana Maia de Oliveira
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

10.  Serine-linked PARP1 auto-modification controls PARP inhibitor response.

Authors:  Evgeniia Prokhorova; Florian Zobel; Rebecca Smith; Siham Zentout; Ian Gibbs-Seymour; Kira Schützenhofer; Alessandra Peters; Joséphine Groslambert; Valentina Zorzini; Thomas Agnew; John Brognard; Michael L Nielsen; Dragana Ahel; Sébastien Huet; Marcin J Suskiewicz; Ivan Ahel
Journal:  Nat Commun       Date:  2021-07-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.